Q-omics provides the consensus-scored MTCYBP2 profile across patient tissues and cancer cell-line models. MTCYBP2 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in MESO. Additionally, MTCYBP2 RNA expression shows 5,563 significant protein co-abundance associations, with the highest sampling consensus in HNSC. Together, these results highlight MESO, and HNSC as cancer lineages where MTCYBP2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MTCYBP2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MTCYBP2 survival associations across molecular data types. MTCYBP2 RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MTCYBP2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	9	MESO (99)	view →

This table ranks reproducible MTCYBP2 RNA expression–survival associations across cancer types. High MTCYBP2 expression shows unfavorable associations in MESO, PAAD, KIRP, ESCA and PRAD, but favorable associations in LAML. The MESO Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .009). Together, the overview and detailed table identify MESO as the clearest survival context for MTCYBP2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.202	0.586	.009	99	view →
PAAD	DFS	Tertile	All	0.006	0.505	<.001	45	view →
KIRP	DFS	Tertile	All	0.593	0.870	.005	33	view →
ESCA	DFS	Tertile	All	0.305	0.542	.024	27	view →
LAML	DFS	Median	All	0.672	0.441	.007	18	view →
PRAD	OS	Tertile	All	0.636	0.921	.015	12	view →

Pink = unfavorable, green = favorable. all 9 lineages →

MTCYBP2-MESO (OS)

Kaplan–Meier survival curve for MTCYBP2 RNA expression in MESO: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MTCYBP2 in patient tissues and cancer cell lines. In patient samples, MTCYBP2 shows the broadest associations at the RNA and protein expression levels, with HNSC recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	5,563	HNSC (2023)	view →
RNA	3,715	COAD (2067)	view →